A new study by a multidisciplinary team from the CMCiB-IGTP and the UPC uses mathematical modelling to provide tantalising insights into how the origin of tuberculosis has affected population growth and female resistance to infection. The study published in Scientific Reports, provides mechanisms by which TB infection has helped to shape human society as we know it.
At the IGTP TODAY
The IGTP has been a member of a European community of practice (CoP) since it signed the memorandum of understanding in August 2019. The community aims to advance gender equality in European centres funding and carrying out research in the Life Sciences. Members of the Can Ruti Campus Working Group Women in Science (WiS) have been participating in activities since then and are currently helping to prepare a staff survey to offer to all the participating centres.
During the coming days many girls and boys are feeding the "tió" and leaving lists of wishes for Santa Claus or the Magic Kings - so we suggest two gifts that will also raise money to help others.
Anthropology joins the battle to tackle TB in the most vulnerable members of society in a new multi-disciplinary project
Cristina Vilaplana and Adrià Pujol-Cruells of the Experimental Tuberculosis Unit at the IGTP have used a novel approach to TB research and applied anthropological methodology to make recommendations on how the set up a patient-oriented approach to treat tuberculosis (TB). The article has been published in Frontiers in medicine.
The IGTP-GTP biobanc has won an award for the best oral presentation of a poster, for the team's work on analysing the work of the biobanc over the past 5 years and evaluating the balance between samples stored and requests for samples made. The team demonstrated that the biobanc is dynamic, receiving a steady increase of requests for samples and is able to respond to changing needs from researchers.
The IRISCAT Alliance is a cooperative work space formed by the 7 research and innovation institutes linked to the ICS, in a first phase; the mechanisms for future incorporation of other centers will be established. The objective of the alliance is to take advantage of the synergies of the institutes to enhance and make the translational and clinical research of the Catalan health system more competitive, in order to enhance this reference hub in southern Europe.
A team at Germans Trias treat a patient with a new bio-implant to repair heart tissue after a heart attack
The pioneering surgery that took place last May at the Germans Trias Hospital. The bio-implant, based on umbilical cord stem cells, has been developed by the Cardiovascular Disease Research Group (ICREC) at Germans Trias, led by Antoni Bayés-Genís in a research line, which they have been pursuing for 10 years. The new therapy has been developed with the collaboration of the Blood and Tissue Bank (BST) and the Institute of Bioengineering of Catalonia (IBEC); this is the first step of the application in clinical practice and the group will continue to monitor safety and the capacity of cardiac tissue to recover
Two groups at the IGTP have taken part in the workshop "Complex Systems" organized by the Èpica Foundation. The experience is a first for the IGTP and has meant that art and science have worked together to produce results for both of them. Èpica is a space for interdisciplinary learning and training for the performing arts run by the Fura dels Baus. The results of the workshop are based on research projects from the IGTP and will be shown this Friday and Saturday 29 and 30 November at the Èpica headquarters in Badalona.
Researchers at the IGTP and Germans Trias Hospital have published new research in Frontiers in Immunology on the behaviour of dendritic cells (DC) during the development of type 1 diabetes (T1D) in children. These cells are involved in both the destruction of beta cells in T1D and the regulation of the immune response. This paper fills an important gap in knowledge about the disease in children.
The Neuromuscular and Neuropediatric Group at the IGTP, led by Gisela Nogales-Gadea have identified a subset of patients with an atypical type of myotonic dystrophy type 1 (MD1), which develops later and with more severe symptoms than usual. This has important implications for diagnosis of these patients, who can be misdiagnosed or not given the correct prognosis. It is also vital for managing the disease correctly in patients and their families. The study has been published in Human Mutation.